UNITED KINGDOM AND IRELAND OESOPHAGOGASTRIC CANCER GROUP
The UKIOG Research Group aims to support research into Oesophagogastric (OG) cancer in the UK & Ireland. More specifically its remit including identifying research needs and priorities for OG cancer in the UK & Ireland to allow for studies most likely to impact on patient care to be prioritised including those aimed at reducing health inequalities
Financial health, per its FY2025 accounts
The accounts state that the charity ended the financial period with unrestricted reserves of £78,659.80 and held no other assets or liabilities. The trustees reported no principal risks facing the charity and confirmed that sponsors were happy to continue funding activities. The independent examiner confirmed that no material matters came to their attention during the examination of the accounts.
What the accounts disclose
“We fund our activities via sponsorship from medical companies. This pays for the events and the remaining money is then available for other activities.”
Trustees
- Professor Thomas David Lewis Crosby OBEchair
- Christopher John Peters
- Dr Elizabeth Catherine Smyth
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £93k | £44k |
| 31/03/2024 | £17k | £18k |
| 31/03/2023 | £50k | £18k |
Common questions
Is UNITED KINGDOM AND IRELAND OESOPHAGOGASTRIC CANCER GROUP financially healthy?
Per its FY2025 accounts: The accounts state that the charity ended the financial period with unrestricted reserves of £78,659.80 and held no other assets or liabilities. The trustees reported no principal risks facing the charity and confirmed that sponsors were happy to continue funding activities. The independent examiner confirmed that no material matters came to their attention during the examination of the accounts. Its FY2025 accounts were independently examined.